Efficient momentum relaxation through umklapp scattering, leading to a power law in temperature dc resistivity, requires a significant low energy spectral weight at finite momentum. One way to achieve this is via a Fermi surface structure, leading to the well-known relaxation rate Γ∼T2. We observe that local criticality, in which energies scale but momenta do not, provides a distinct route to efficient umklapp scattering. We show that umklapp scattering by an ionic lattice in a locally critical theory leads to Γ∼T(2Δ(k(L))). Here Δ(k(L))≥0 is the dimension of the (irrelevant or marginal) charge density operator J(t)(ω,k(L)) in the locally critical theory, at the lattice momentum k(L). We illustrate this result with an explicit computation in locally critical theories described holographically via Einstein-Maxwell theory in Anti-de Sitter spacetime. We furthermore show that scattering by random impurities in these locally critical theories gives a universal Γ∼(log(1/T))(-1).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1103/PhysRevLett.108.241601 | DOI Listing |
Alzheimers Dement
December 2024
Department of Bioengineering, University of California, Los Angeles, CA, USA, Los Angeles, CA, USA.
Background: The initiation of amyloid plaque deposition signifies a crucial stage in Alzheimer's disease (AD) progression, which often coincides with the disruption of neural circuits and cognitive decline. While the role of excitatory-inhibitory balance is increasingly recognized in AD pathophysiology, targeted therapies to modulate this balance remain underexplored. This study investigates the effect of perampanel, a selective non-competitive AMPA receptor antagonist, in modulating neurophysiological changes in hAPP-J20 transgenic Alzheimer's mice.
View Article and Find Full Text PDFBackground: Early-onset Alzheimer's disease (EOAD) associated with amyloid precursor protein (APP) duplications or presenilin (PSEN) variants increases risk of seizures. Targeting epileptiform activity with antiseizure medicine (ASM) administration to AD patients may beneficially attenuate cognitive decline (Vossel et al, JAMA Neurology 2021). However, whether mechanistically distinct ASMs differentially suppress seizures in discrete EOAD models is understudied (Lehmann et al, Neurochem Res 2021).
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Real-World data platforms for Alzheimer's Disease (AD) offer a unique opportunity to improve health equity through better understanding of health disparities and inclusivity in research, which is critical to translatability of research findings. AD research in the US and globally remains largely inaccessible to many individuals due to individual-level, study-level, investigator-level and larger systemic barriers. ALZ-NET, a US-based registry to evaluate longitudinal outcomes of patients being evaluated for or treated with novel FDA-approved AD therapy, and New IDEAS, an observational US-based longitudinal study of amyloid PET clinical utility, both offer opportunities for examining care, inclusivity, and disparities.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Pittsburgh Alzheimer's Disease Research Center (ADRC), Pittsburgh, PA, USA.
Background: Increasing calls for diversity in Alzheimer's disease and related dementias (ADRDesearch have fueled significant investments in recruitment personnel and activities. However, the essential work of identifying and authentically engaging communities of color in relationship-building begins well before, and continues long after, study recruitment activities take place. The purpose of this presentation is twofold: 1) to differentiate the work of trust-building and relationship cultivation from that of research study recruitment, and 2) to describe the necessary steps to ensure that relationship cultivation is ongoing and supported beyond the timeline of a singular research study.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Otsuka America Pharmaceutical Inc., Princeton, NJ, USA.
Background: Language serves as a powerful tool in shaping perceptions and reinforcing societal norms. Current understanding suggests that the language used to describe dementia can impact how the condition is perceived, understood, and addressed within various cultural contexts. Further, language can play a pivot role in shaping caregiving practices, willingness to seek medical care, and the openness, or lack thereof, to speak about the condition.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!